Bernard Moss

50PUBLICATIONS
56CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Nanotoxicology, health and safetyPlant and fungus systematics and taxonomyGlycoconjugatesMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (50)

|Sep 29, 2026
Real-time tracking of vaccinia virus entry using a split luciferase complementation assay.

|Jun 10, 2026
Immunogenicity of poxvirus A16/G9 entry-fusion subcomplex and its restriction by A56/K2 protein informs vaccine design.

|Jun 26, 2025
Antibody Binding and Neutralizing Targets within the Predicted Structure of the Poxvirus Multiprotein Entry-Fusion Complex.

Huibin Yu, Wolfgang Resch, Catherine A Cotter

|Jun 26, 2025
The 2.3 Å Structure of A21, a Protein Component of the Conserved Poxvirus Entry-Fusion Complex.

Ulrike S Diesterbeck, Liya A Muslinkina, Apostolos G Gittis

|May 23, 2025
Identification and characterization of O-GlcNAc modifications of a conserved orthopoxvirus core protein.

Yunliang Zhang, Bernard Moss

|May 21, 2025
Mpox multiprotein virus-like nanoparticle vaccine induces neutralizing and protective antibodies in mice and non-human primates.

Ahmed A Belghith, Catherine A Cotter, Maxinne A Ignacio

Pageof 9

Frequent Collaborators

5 joint publications

Catherine A Cotter

3 joint publications

Chen Peng

1 joint publications

Sailaja Gangadhara

1 joint publications

David C Montefiori